CTLs can identify and kill cells expressing tumor-specific antigens, directly eliminating tumor cells by releasing perforin and granzymes, while promoting the formation of immune memory and producing cytokines such as IFN-γ, which can inhibit tumor cell growth and enhance the anti-tumor activity of other immune cells [61]. The gene discussed is IFNG; the disease is neoplasm.